Intabio

About:

Intabio is a developer of a real-time protein analytics platform used to transform the development of biotherapeutic drug.

Website: http://www.intabio.com

Twitter/X: intabio

Top Investors: National Science Foundation, Northpond Ventures, CSC Upshot, Genoa Ventures, Vertical Venture Partners

Description:

Intabio is a Silicon Valley-based company developing analytical solutions to transform biotherapeutic development and manufacturing with products that provide early product quality characterization and profound efficiency gains across all stages of biopharmaceutical development and manufacturing. Intabio was founded in 2015 by Erik Gentalen and Lena Wu and is based in Fremont, California, United States.

Total Funding Amount:

$35.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Fremont, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)intabio.com

Founders:

Erik Gentalen, Lena Wu

Number of Employees:

11-50

Last Funding Date:

2020-02-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai